日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.

Botensilimab 是一种 Fc 增强型抗 CTLA-4 抗体,对传统免疫疗法反应不佳的肿瘤有效

Chand Dhan, Savitsky David A, Krishnan Shanmugarajan, Mednick Gabriel, Delepine Chloe, Garcia-Broncano Pilar, Soh Kah Teong, Wu Wei, Wilkens Margaret K, Udartseva Olga, Vincent Sylvia, Joshi Bishnu, Keith Justin G, Manrique Mariana, Marques Marilyn, Tanne Antoine, Levey Daniel L, Han Haiyong, Ng Serina, Ridpath Jackson, Huber Olivia, Morin Benjamin, Galand Claire, Bourdelais Sean, Gombos Randi B, Ward Rebecca, Qin Yu, Waight Jeremy D, Costa Matthew R, Sebastian-Yague Alvaro, Rudqvist Nils-Petter, Pupecka-Swider Malgorzata, Venkatraman Vignesh, Slee Andrew, Patel Jaymin M, Grossman Joseph E, Wilson Nicholas S, Von Hoff Daniel D, Stebbing Justin, Curiel Tyler J, Buell Jennifer S, O'Day Steven J, Stein Robert B

Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies

激活Fcγ受体有助于免疫调节受体靶向抗体的抗肿瘤活性

Bulliard, Yannick; Jolicoeur, Rose; Windman, Maurice; Rue, Sarah M; Ettenberg, Seth; Knee, Deborah A; Wilson, Nicholas S; Dranoff, Glenn; Brogdon, Jennifer L

Host genetic background impacts modulation of the TLR4 pathway by RON in tissue-associated macrophages

宿主遗传背景影响RON对组织相关巨噬细胞中TLR4通路调控的作用

Chaudhuri, Amitabha; Wilson, Nicholas S; Yang, Becky; Paler Martinez, Andres; Liu, Jinfeng; Zhu, Catherine; Bricker, Nicole; Couto, Suzana; Modrusan, Zora; French, Dorothy; Cupp, James; Ashkenazi, Avi

ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway

ISCOMATRIX疫苗通过MyD88依赖性信号通路介导CD8+ T细胞交叉启动

Wilson, Nicholas S; Yang, Becky; Morelli, Adriana Baz; Koernig, Sandra; Yang, Annie; Loeser, Stefanie; Airey, Denise; Provan, Larissa; Hass, Phil; Braley, Hal; Couto, Suzana; Drane, Debbie; Boyle, Jeff; Belz, Gabrielle T; Ashkenazi, Avi; Maraskovsky, Eugene